FDA Approvals

Date Posted
Article Title
3/25/2010
Xifaxan Approved for People With Liver Disease

To treat disorder that affects brain function

3/18/2010
Carbaglu Approved for Rare Genetic Disorder

Causes elevated ammonia in blood

3/17/2010
Implanted Hearing System Approved

To treat senorineural hearing loss

3/12/2010
Pelvic Artery Stent Approved

Props open vessel that supplies blood to the legs

3/9/2010
Botox Approved for Spasticity in Stroke Victims

A common aftereffect of stroke

3/4/2010
Heartburn Drug Kapidex Renamed to Dexilant

FDA approves name change to avoid confusion with other drugs

3/2/2010
Generic Flomax Approved for Enlarged Prostate

A common condition in older men

2/26/2010
2/24/2010
Successor to Combination Pneumococcal Vaccine Approved

Prevnar 13 offers broader protection against a host of bacterial diseases

2/24/2010
2/22/2010
2/19/2010
Rituxan Approved for Chronic Lymphocytic Leukemia

A cancer of the blood and bone marrow

2/11/2010
2/9/2010
2/3/2010
Xiaflex Approved for Rare Hand Condition

Dupuytren's contracture limits finger use

2/1/2010
Approval Expanded for Breast Cancer Drug Tykerb

To include certain postmenopausal women who need hormone therapy

1/26/2010
Victoza Sanctioned for Type 2 Diabetes

But it may cause thyroid tumors and other side effects, FDA says

1/26/2010
Morphine Sulfate Solution Approved

For acute and chronic pain

1/25/2010
Heart Valve Implanted Via Catheter Approved

Inserted by way of a tube in a leg vein and guided up to the heart

1/22/2010
Ampyra Approved for Adults With MS

Helps those who have trouble walking